Nectar Lifesciences Limited
NSE: NECLIFE BSE: NECLIFE
NSE
15.87
0.57 (3.73%)
Prev Close
15.3
Open Price
15.45
Volume
563,118
Today Low / High
15.05 / 16
52 WK Low / High
13.05 / 56.5
Range
15 - 17
BSE
15.79
0.50 (3.27%)
Prev Close
15.29
Open Price
15.3
Volume
29,953
Today Low / High
15 / 15.99
52 WK Low / High
13.25 / 56.39
Range
15 - 17
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 15.87 (target range: 15 - 17), reflecting a change of 0.57 (3.72549%). On the BSE, it is listed at 15.79 (target range: 15 - 17), showing a change of 0.5 (3.27011%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
22 Aug
15.45
2.72%
21 Aug
15.39
-0.58%
20 Aug
14.99
0.60%
19 Aug
15.11
-0.46%
18 Aug
14.20
6.41%
14 Aug
14.82
-2.02%
13 Aug
15.88
-4.09%
12 Aug
15.00
2.93%
11 Aug
14.29
2.94%
08 Aug
13.20
6.14%
07 Aug
13.36
-0.07%
06 Aug
14.50
-3.24%
05 Aug
15.10
-2.19%
04 Aug
16.24
-4.62%
01 Aug
16.41
-0.98%
31 Jul
16.60
-1.14%
30 Jul
16.40
1.34%
29 Jul
16.57
-0.78%
28 Jul
17.30
-4.22%
Nectar Lifesciences Limited Graph
Nectar Lifesciences Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Nectar Lifesciences Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 15.87, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 15.79 | 15.95 | 14.35 - 17.54 |
| 16.11 | 12.88 - 19.33 | ||
| 16.26 | 11.38 - 21.14 | ||
| Bearish Scenario | 15.79 | 15.63 | 14.07 - 17.20 |
| 15.47 | 12.38 - 18.57 | ||
| 15.32 | 10.72 - 19.91 |
Overview of Nectar Lifesciences Limited
ISIN
INE023H01027
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
2,739,407
Market Cap
3,559,022,070
Last Dividend
0
Official Website
IPO Date
2005-07-18
DCF Diff
-12.10
DCF
27
Financial Ratios Every Investor Needs
Stock Dividend of NECLIFE
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2020-09-11 | September 11, 20 | 4.3195 | 4.3195 | 2020-09-14 | 2020-10-21 | |
| 2019-09-19 | September 19, 19 | 4.3195 | 4.3195 | 2019-09-21 | 2019-10-27 | 2019-05-25 |
| 2018-09-19 | September 19, 18 | 4.3195 | 4.3195 | 2018-09-21 | 2018-10-27 | 2018-05-28 |
| 2017-09-20 | September 20, 17 | 4.3195 | 4.3195 | 2017-09-21 | 2017-10-28 | 2017-06-27 |
| 2016-09-22 | September 22, 16 | 8.639 | 8.639 | 2016-09-23 | 2016-10-30 | 2016-05-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,669.97 Cr | 1,368.01 Cr | 301.96 Cr | 0.1808 | 0.00 Cr | 0.00 Cr | -88.85 Cr | -113.68 Cr | -5.07 | -24.57 Cr | -0.0681 |
| 2024-03-31 | 1,684.09 Cr | 1,202.24 Cr | 481.84 Cr | 0.2861 | 6.71 Cr | 17.19 Cr | 389.06 Cr | 5.00 Cr | 0.22 | 168.61 Cr | 0.0030 |
| 2023-03-31 | 1,523.67 Cr | 1,465.68 Cr | 57.99 Cr | 0.0381 | 15.32 Cr | 14.28 Cr | -5.17 Cr | -24.18 Cr | -1.08 | 99.50 Cr | -0.0159 |
| 2022-03-31 | 1,668.83 Cr | 1,369.51 Cr | 299.33 Cr | 0.1794 | 3.07 Cr | 15.02 Cr | 101.60 Cr | 25.05 Cr | 1.12 | 160.99 Cr | 0.0150 |
| 2021-03-31 | 1,543.30 Cr | 1,285.73 Cr | 257.57 Cr | 0.1669 | 2.44 Cr | 17.41 Cr | 62.01 Cr | -73.26 Cr | -3.27 | 61.25 Cr | -0.0475 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 19.22 Cr | 2,047.23 Cr | 1,091.12 Cr | 956.1068 Cr | 582.02 Cr | 562.80 Cr | 690.16 Cr | 633.33 Cr | 0.00 Cr | 0.00 Cr | 11.97 Cr | 1,021.5414 Cr |
| 2024-03-31 | 19.81 Cr | 2,191.06 Cr | 1,121.81 Cr | 1,069.2470 Cr | 635.54 Cr | 615.73 Cr | 776.53 Cr | 656.06 Cr | 0.00 Cr | 0.75 Cr | -0.26 Cr | 972.8170 Cr |
| 2023-03-31 | 17.58 Cr | 2,189.21 Cr | 1,124.62 Cr | 1,064.5946 Cr | 753.83 Cr | 736.25 Cr | 672.60 Cr | 690.43 Cr | 0.00 Cr | 0.77 Cr | 0.24 Cr | 890.9270 Cr |
| 2022-03-31 | 17.78 Cr | 2,390.83 Cr | 1,302.93 Cr | 1,087.9040 Cr | 859.93 Cr | 842.15 Cr | 721.26 Cr | 765.17 Cr | 0.00 Cr | 0.80 Cr | 0.24 Cr | 1,003.8330 Cr |
| 2021-03-31 | 25.50 Cr | 2,388.11 Cr | 1,326.09 Cr | 1,062.0290 Cr | 903.41 Cr | 877.91 Cr | 655.32 Cr | 832.15 Cr | 6.71 Cr | 0.82 Cr | 0.24 Cr | 1,187.3920 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 169.4380 Cr | -41.9304 Cr | -128.0920 Cr | 125.6432 Cr | -0.5844 Cr | 19.2216 Cr | -43.7948 Cr | -161.5340 Cr | -53.5137 Cr | 0.0000 Cr | 0.0000 Cr |
| 2024-03-31 | 224.6860 Cr | -17.0250 Cr | -205.4350 Cr | 195.2710 Cr | 2.2260 Cr | 19.8060 Cr | -29.4150 Cr | 4.9950 Cr | -118.2930 Cr | 0.0000 Cr | 0.0000 Cr |
| 2023-03-31 | 133.6510 Cr | 51.7040 Cr | -185.5830 Cr | 103.5910 Cr | -0.2280 Cr | 17.5800 Cr | -30.0600 Cr | -42.4199 Cr | -109.0960 Cr | 0.0000 Cr | 0.0000 Cr |
| 2022-03-31 | 95.0050 Cr | 16.6440 Cr | -119.3800 Cr | 70.0350 Cr | -7.7310 Cr | 17.8080 Cr | -24.9700 Cr | 34.0800 Cr | -50.5690 Cr | 0.0000 Cr | 0.0000 Cr |
| 2021-03-31 | 21.3790 Cr | -28.6240 Cr | 11.4900 Cr | -9.8620 Cr | 4.2450 Cr | 25.5390 Cr | -31.2410 Cr | -59.4530 Cr | 32.3540 Cr | -1.1210 Cr | 0.0000 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 280.67 Cr | 263.54 Cr | 17.13 Cr | 0.0610 | -78.41 Cr | -63.23 Cr | -2.82 | -61.54 Cr | -0.2253 |
| 2025-03-31 | 428.91 Cr | 502.58 Cr | -73.68 Cr | -0.1718 | -170.07 Cr | -130.09 Cr | -5.80 | -154.23 Cr | -0.3033 |
| 2024-12-31 | 454.33 Cr | 332.04 Cr | 122.29 Cr | 0.2692 | 29.10 Cr | 7.84 Cr | 0.35 | 45.28 Cr | 0.0173 |
| 2024-09-30 | 427.88 Cr | 296.04 Cr | 131.84 Cr | 0.3081 | 27.78 Cr | 5.60 Cr | 0.25 | 44.02 Cr | 0.0131 |
| 2024-06-30 | 358.85 Cr | 276.79 Cr | 82.06 Cr | 0.2287 | 24.34 Cr | 2.97 Cr | 0.13 | 40.35 Cr | 0.0083 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 19.22 Cr | 8.04 Cr | 27.26 Cr | 346.34 Cr | 690.16 Cr | 1,237.59 Cr | 633.33 Cr | 2,047.23 Cr | 1,091.12 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 18.73 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,077.82 Cr |
| 2024-09-30 | 18.24 Cr | 0.49 Cr | 18.73 Cr | 380.13 Cr | 749.38 Cr | 1,305.43 Cr | 633.29 Cr | 2,183.23 Cr | 1,105.42 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 20.30 Cr | 0.00 Cr | 0.00 Cr | 20.30 Cr | 0.00 Cr | 0.00 Cr | -1,069.25 Cr |
| 2024-03-31 | 19.81 Cr | 0.50 Cr | 20.30 Cr | 379.19 Cr | 776.53 Cr | 1,283.83 Cr | 656.06 Cr | 2,191.06 Cr | 1,121.81 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 7.84 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 5.60 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 2.97 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.59 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 1.57 Cr | 30.75 Cr | 0.00 Cr | 0.00 Cr | 30.75 Cr | 50.78 Cr | 20.04 Cr | 0.00 Cr | 30.75 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2008-11-12 | November 12, 08 | 10:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,641.80 | ₹3,939,137,904,000.00 | ₹2,098,280.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,151.50 | ₹1,633,032,553,500.00 | ₹681,521.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,685.30 | ₹1,247,271,358,500.00 | ₹279,863.00 |
| Mankind Pharma Limited | MANKIND | ₹2,606.80 | ₹1,075,901,331,568.00 | ₹731,305.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,277.60 | ₹1,063,387,459,020.00 | ₹1,229,762.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹988.80 | ₹994,960,224,000.00 | ₹307,413.00 |
| Lupin Limited | LUPIN | ₹1,974.70 | ₹901,938,300,900.00 | ₹380,522.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,426.00 | ₹648,759,690,000.00 | ₹99,581.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,050.40 | ₹610,074,420,800.00 | ₹1,872,840.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,937.30 | ₹546,707,997,300.00 | ₹466,930.00 |
| Laurus Labs Limited | LAURUSLABS | ₹879.10 | ₹474,560,157,500.00 | ₹1,548,001.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,418.40 | ₹359,853,753,600.00 | ₹437,395.00 |
| Cohance Lifesciences Limited | COHANCE | ₹884.70 | ₹338,457,031,978.00 | ₹105,334.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,638.50 | ₹329,643,636,000.00 | ₹49,045.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,747.90 | ₹273,268,433,900.00 | ₹250,994.00 |
| Piramal Enterprises Limited | PEL | ₹1,167.70 | ₹264,691,900,600.00 | ₹183,898.00 |
| Eris Lifesciences Limited | ERIS | ₹1,768.70 | ₹240,909,320,900.00 | ₹37,828.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,479.40 | ₹240,371,432,600.00 | ₹246,819.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,433.00 | ₹210,825,000,000.00 | ₹11,150.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹974.60 | ₹191,570,299,800.00 | ₹29,498.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,888.00 | ₹178,181,651,200.00 | ₹28,474.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹1,083.00 | ₹172,501,323,000.00 | ₹140,398.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹2,168.10 | ₹164,800,966,770.00 | ₹172,510.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹882.45 | ₹158,055,619,500.00 | ₹259,072.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Granules India Limited | GRANULES | ₹458.50 | ₹111,252,274,000.00 | ₹945,550.00 |
| Procter & Gamble Health Limited | PGHL | ₹6,581.50 | ₹109,248,951,100.00 | ₹46,177.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹851.90 | ₹83,308,067,710.00 | ₹36,218.00 |
| Strides Pharma Science Limited | STAR | ₹865.50 | ₹79,775,471,850.00 | ₹92,326.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹863.25 | ₹78,240,335,715.00 | ₹294,141.00 |
| FDC Limited | FDC | ₹474.65 | ₹77,277,766,500.00 | ₹198,253.00 |
| Innova Captab Limited | INNOVACAP | ₹911.35 | ₹52,151,939,956.00 | ₹70,484.00 |
| Suven Life Sciences Limited | SUVEN | ₹230.75 | ₹50,320,575,500.00 | ₹56,095.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹146.08 | ₹47,406,173,760.00 | ₹195,028.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹483.05 | ₹44,087,973,500.00 | ₹160,106.00 |
| Sequent Scientific Limited | SEQUENT | ₹175.85 | ₹44,021,409,750.00 | ₹240,104.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹772.20 | ₹39,165,289,020.00 | ₹31,316.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,358.20 | ₹39,002,269,800.00 | ₹5,512.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹363.25 | ₹36,425,983,500.00 | ₹39,528.00 |
| Unichem Laboratories Limited | UNICHEMLAB | ₹502.80 | ₹35,400,036,240.00 | ₹9,585.00 |
| Hikal Limited | HIKAL | ₹254.90 | ₹31,429,424,900.00 | ₹3,140,867.00 |
| Solara Active Pharma Sciences Limited | SOLARA | ₹631.60 | ₹30,413,434,800.00 | ₹53,855.00 |
| IOL Chemicals and Pharmaceuticals Limited | IOLCP | ₹96.82 | ₹28,419,284,140.00 | ₹848,541.00 |
| Alembic Limited | ALEMBICLTD | ₹105.52 | ₹27,095,636,534.00 | ₹249,022.00 |
| Morepen Laboratories Limited | MOREPENLAB | ₹49.03 | ₹26,866,184,620.00 | ₹2,369,065.00 |
| Indoco Remedies Limited | INDOCO | ₹279.55 | ₹25,787,900,445.00 | ₹12,570.00 |
Key Executives
Chief Executive Officer
Mr. Amit Chadah
Gender: male
Year Born: 1970
Chairman & MD
Mr. Sanjiv Goyal
Gender: male
Year Born: 1960
Director of Operations & Wholetime Director
Mr. Puneet Sud B.Tech.
Gender: male
Year Born: 1967
Chief Financial Officer
Mr. Sushil Kapoor
Gender: male
Year Born: 1958
Chief Operating Officer
Mr. Vikas Vij
Gender: male
Year Born: 1967
Company Secretary & Compliance Officer
Mr. Sanjaymohan Singh Rawat
Gender: male
Year Born:
FAQs about Nectar Lifesciences Limited
Who is the CEO of the company?
The CEO is Amit Chadah.
What is the current market price of the stock?
The current price is ₹15.87.
What is the 52-week price range?
The range is ₹13.05-56.5.
What is the market capitalization of the company?
The market capitalization is ₹355.90 crores.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is -1.98.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Nectar Lifesciences Limited (ISIN: INE023H01027) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹355.90 crores and an average daily volume of 2,739,407 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹0.